Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test
Comprehensive Drug Susceptibility Testing for Tuberculosis
The Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test represents a critical advancement in tuberculosis management, providing healthcare providers with essential information about drug resistance patterns in Mycobacterium tuberculosis complex. This sophisticated diagnostic tool is specifically designed to evaluate bacterial susceptibility to five first-line anti-tuberculosis medications, enabling physicians to create personalized treatment strategies for patients with drug-resistant TB.
What This Test Measures and Detects
This comprehensive panel evaluates Mycobacterium tuberculosis complex susceptibility to five essential anti-tuberculosis medications:
- Streptomycin – An aminoglycoside antibiotic used in TB treatment regimens
- Isoniazid – A cornerstone first-line anti-tuberculosis drug
- Rifampicin – A key bactericidal agent in TB therapy
- Ethambutol – Used to prevent resistance development
- Pyrazinamide – Essential for sterilizing activity against persistent bacilli
The test utilizes Automated Fluorescent technology to provide rapid, accurate results, detecting even low-level resistance that might compromise treatment effectiveness.
Who Should Consider This Test
This test is recommended for individuals who:
- Show poor response to standard tuberculosis treatment
- Have recurrent TB symptoms after completing initial therapy
- Have been exposed to drug-resistant TB strains
- Are immigrants from regions with high TB drug resistance rates
- Have HIV co-infection with tuberculosis
- Experience treatment failure with first-line medications
- Have close contacts with drug-resistant TB patients
Clinical Benefits of Drug Susceptibility Testing
Undergoing the Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test provides numerous advantages:
- Personalized Treatment Planning – Enables physicians to select the most effective medications based on individual resistance patterns
- Prevention of Treatment Failure – Identifies drug resistance early to avoid ineffective therapy
- Reduced Transmission Risk – Helps control the spread of drug-resistant strains
- Cost-Effective Care – Prevents unnecessary medication expenses by targeting effective drugs
- Improved Patient Outcomes – Leads to better treatment success rates and reduced complications
- Public Health Benefits – Contributes to monitoring drug resistance trends in the community
Understanding Your Test Results
Your test results will provide detailed information about which anti-tuberculosis medications remain effective against your specific Mycobacterium tuberculosis strain:
- Susceptible Results – Indicates the medication is likely to be effective against your TB strain
- Resistant Results – Suggests the medication may not work effectively, requiring alternative treatment options
- Intermediate Results – May indicate reduced effectiveness, requiring careful clinical interpretation
Your physician will use these results to design a customized treatment regimen that maximizes effectiveness while minimizing side effects and treatment duration.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test | $238 USD | $326 USD |
Nationwide Accessibility
We have diagnostic branches conveniently located across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our facilities are equipped with state-of-the-art technology and staffed by experienced professionals dedicated to providing accurate, reliable results.
Take Control of Your Tuberculosis Treatment
Don’t leave your tuberculosis treatment to chance. The Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test provides the critical information needed to ensure your treatment is effective and tailored to your specific infection. With drug-resistant tuberculosis becoming increasingly common, this test represents an essential step toward successful recovery.
Call us today at +1(267) 388-9828 to schedule your test or speak with our healthcare specialists about whether this comprehensive drug susceptibility panel is right for your situation. Early detection of drug resistance can significantly improve your treatment outcomes and quality of life.
Our team is available to answer your questions, explain the testing process, and help you understand how these results can guide your tuberculosis treatment journey toward complete recovery.
